HENDERSON MICHAEL THOMAS (Chief Executive Officer) sold 1.7% of their position (20K shares) of APOGEE THERAPEUTICS, INC. on the open market
Open‑market sale worth $1.65M — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 4/11/2026ACC: 0001104659-26-042155
DirectorOfficer· Chief Executive Officer
Since Feb 2026
-20K
Net shares
Net seller
$1.65M
Total sold
3
Open market trades
0B · 3S
3
Total transactions
20K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
−17.80K
Price / share
$82.48
Trade value
$1.47M
% of position
1.5%
4/8/2026
1.15M→1.14M
Common Stock
Direct
Shares
−2K
Price / share
$83.26
Trade value
$166.52K
% of position
0.2%
4/8/2026
1.14M→1.13M
Common Stock
Direct
Shares
−200.00
Price / share
$85.00
Trade value
$17K
% of position
0.0%
4/8/2026
1.13M→1.13M
Total
Net shares
−20K
Net value
-$1.65M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/8/2026 | S · Sale | −17.80K | $82.48 | $1.47M | 1.5% | 1.15M | 1.14M |
| Common Stock Direct | 4/8/2026 | S · Sale | −2K | $83.26 | $166.52K | 0.2% | 1.14M | 1.13M |
| Common Stock Direct | 4/8/2026 | S · Sale | −200.00 | $85.00 | $17K | 0.0% | 1.13M | 1.13M |
| Total | −20K | -$1.65M | ||||||
Derivative Transactions0
No derivative transactions reported